
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+7
Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and FAK inhibition. Pursuing unexplored pathways demands that were purposeful in everything we do. And its an endeavor thats only possible with an experienced team of employees and partners dedicated to a singular purpose: changing and improving the way cancer is treated by...
Oncology,pharmaceutical,hematology,biotechnology,cancer,clinical trials,cancer research,blood cancer,cll,lymphoma,nhl,and t cell lymphoma
Verastem oncology operates in the Biotechnology research industry.
Verastem oncology's revenue is 1m - 10m
Verastem oncology has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.